Risk of Veteran suicide is elevated during the first year of transition from military service to civilian life. Most Veteran suicides occur among Veterans who are not connected to VA healthcare. Suicide prevention and connection to care are therefore critical for recently transitioning Veterans. Transitioning Veterans require services to provide them with suicide prevention education, skills to manage their transition effectively, and support in their access to VA healthcare. Convenient, accessible, palatable, patient-centered care options that are cost-effective, easy to implement nationwide, and target domains known to mitigate suicide risk are needed during this critical transition period. This proposal would bridge this important healthcare gap using STEP-Home-SP, a transdiagnostic, non-stigmatizing, skills-based workshop. STEP-Home-SP will provide Veterans with suicide prevention education, skills to improve transition, support to access VA care, and a platform to decrease social isolation early in their military to civilian transition, thereby reducing suicide risk downstream.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Feasibility- recruitment interest
Timeframe: Through study completion, an average of one year.
Feasibility- enrollment
Timeframe: Through study completion, an average of one year.
Feasibility- qualitative via Narrative Evaluation of Intervention Interview
Timeframe: Through study completion, an average of 3 months.
Feasibility- Treatment Fidelity/adherence
Timeframe: Through study completion, an average of 1 week.
Acceptability- Veteran adherence
Timeframe: Through study completion, an average of one year.
Acceptability- Quantitative satisfaction via Client satisfaction questionnaire Change
Timeframe: Assessed at baseline (0 weeks), T4 (after 12 weeks), and T5 (after 24 weeks)
Reintegration status- Military to Civilian Questionnaire (M2CQ) Change
Timeframe: Assessed at screening, baseline (0 weeks), T4 (after 12 weeks) and T5 (after 24 weeks)